Products & safety
Toxicology: hazard, exposure, and risk
On this page
A hazard is a potential to cause harm. Assessing risk also requires understanding who is exposed, how much, by which route, and for how long.[1]
Four linked questions
EPA separates hazard identification, dose–response assessment, exposure assessment, and risk characterization. Exposure assessment considers routes, magnitude, duration, frequency, and affected populations.[1]
Why chemical names alone do not describe exposure risk
Risk depends on dose, exposure route, duration, and timing. Inhalation, ingestion, and skin contact differ. Absorption, distribution, metabolism, and elimination affect internal dose. EPA considers susceptible populations and exposure-effect relationships; a chemical name on a label cannot quantify personal harm.[1]
Finding a chemical in blood or urine is not a disease diagnosis
CDC biomonitoring measures chemicals or their breakdown products in people, helping describe population exposure. Detection alone does not demonstrate that the amount causes illness. A population percentile says how a measurement compares with that population; it is not automatically a health-based threshold. Further studies of exposure and effects are needed to interpret health risk. Differences in timing and specimen type also matter when comparing measurements.[3]
Hormonal interference is a specific mechanism, not a catch-all label
Endocrine-disrupting chemicals can mimic, block or otherwise interfere with hormone signaling. Relevant exposures can occur through food, water, air or skin, and examples include some pesticides and packaging-related chemicals. Hormonal systems work at low concentrations, so risk questions cannot always be reduced to an assumption that only visibly large doses matter. Evidence still needs the chemical, exposure, developmental context and outcome; a broad category does not diagnose an individual’s symptoms.[4]
ATSDR screening levels specify route, units and duration
| Dimension | Meaning in the MRL framework |
|---|---|
| Oral exposure | Daily dose can be expressed as mg/kg/day.[5] |
| Inhalation exposure | Concentration can be expressed as ppm or mg/m3.[5] |
| Acute | 1–14 days.[5] |
| Intermediate | More than 14 days and fewer than 365.[5] |
| Chronic | 365 days or longer.[5] |
A screening level is not a binary poisoning diagnosis
ATSDR’s minimal risk levels address specified non-cancer exposure questions. They help assess where closer investigation may be needed, rather than defining cleanup levels or diagnosing a person. ATSDR explicitly says that exposure above an MRL does not mean adverse effects will occur.[5]
The workplace hierarchy addresses exposure before relying on personal protection
| Control | What it does |
|---|---|
| Elimination | Remove hazard.[6] |
| Substitution | Replace; assess new risks.[6] |
| Engineering controls | Change process or environment.[6] |
| Administrative controls | Change practices.[6] |
| Personal protective equipment | Suitable equipment, correct use.[6] |
Reducing an exposure is a different question from interpreting a body measurement
These controls cannot diagnose poisoning.[6]
Evidence & uncertainty
Detection alone does not quantify a person’s health risk. Missing exposure or effect information creates uncertainty; it does not establish either safety or harm.[2]
Selected-source overview · Independent review pendingPublished questions
Is detecting a chemical the same as measuring its health risk?
Selected-source overview · Independent review pending. Read the evidence context.
No. Exposure and evidence about harmful effects also matter.[1]
Evidence behind this answer
- Conducting a Human Health Risk Assessment
agency explanation · Date not stated
Selected page sections · Four assessment steps; exposure assessment
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does incomplete toxicology evidence prove a substance is safe?
Selected-source overview · Independent review pending. Read the evidence context.
No. Risk assessments must explain their uncertainty and data gaps.[2]
Evidence behind this answer
- About Risk Assessment
agency explanation · Date not stated
Selected page sections · Risk basics; data limitations and uncertainty
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why do exposure route and duration matter?
Selected-source overview · Independent review pending. Read the evidence context.
They help define the exposure scenario being assessed.[1]
Evidence behind this answer
- Conducting a Human Health Risk Assessment
agency explanation · Date not stated
Selected page sections · Four assessment steps; exposure assessment
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why distinguish a hazard from a risk estimate?
Selected-source overview · Independent review pending. Read the evidence context.
A hazard identifies potential harm; risk assessment also needs an exposure amount, route, duration and affected population.[1]
Evidence behind this answer
- Conducting a Human Health Risk Assessment
agency explanation · Date not stated
Selected page sections · Four assessment steps; exposure assessment
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are variability and uncertainty the same thing in toxicology?
Selected-source overview · Independent review pending. Read the evidence context.
No. Variability describes real differences in exposure or susceptibility; uncertainty describes limitations in what the evidence lets us know.[2]
Evidence behind this answer
- About Risk Assessment
agency explanation · Date not stated
Selected page sections · Risk basics; data limitations and uncertainty
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a detectable chemical in my blood prove that it is making me ill?
Selected-source overview · Independent review pending. Read the evidence context.
No. CDC distinguishes evidence of exposure from evidence of a health effect; detecting a substance is not itself a diagnosis.[3]
Evidence behind this answer
- About the National Report on Human Exposure to Environmental Chemicals
agency explanation · 2026-08-03
Selected page text; cited sections · Biomonitoring, population reference data and interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is a population exposure percentile a safe-versus-unsafe cutoff?
Selected-source overview · Independent review pending. Read the evidence context.
No. It compares measurements with a population distribution and is not automatically a health-based limit.[3]
Evidence behind this answer
- About the National Report on Human Exposure to Environmental Chemicals
agency explanation · 2026-08-03
Selected page text; cited sections · Biomonitoring, population reference data and interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do all endocrine disruptors have the same risk at any exposure?
Selected-source overview · Independent review pending. Read the evidence context.
No. The chemical, route, timing, amount and outcome remain essential, even though hormonal interference is a shared mechanism category.[4]
Evidence behind this answer
- Endocrine Disruptors
agency explanation · 2026-03-06
Selected page text; cited sections · Hormonal interference, routes and evidence examples
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why isn't finding a chemical in the body enough to show it is causing poisoning?
Selected-source overview · Independent review pending. Read the evidence context.
Detection demonstrates exposure, not necessarily poisoning. A hazard is a substance's potential to harm; risk depends on the absorbed dose, entry route, timing and duration, susceptibility, and evidence of clinical effects. Blood or urine concentrations need interpretation against relevant exposure–effect evidence. Presence alone establishes neither a disease diagnosis nor a guarantee of safety.[1][3]
Evidence behind this answer
- Conducting a Human Health Risk Assessment
agency explanation · Date not stated
Selected page sections · Four assessment steps; exposure assessment - About the National Report on Human Exposure to Environmental Chemicals
agency explanation · 2026-08-03
Selected page text; cited sections · Biomonitoring, population reference data and interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does exposure above a minimal risk level automatically diagnose poisoning?
Selected-source overview · Independent review pending. Read the evidence context.
No. ATSDR says exceeding an MRL does not mean adverse effects will occur. It is a screening tool for closer assessment.[5]
Evidence behind this answer
- About Minimal Risk Levels
agency exposure assessment framework · 2024
Selected relevant official page passages inspected · 12 November 2024: non-cancer scope, screening purpose, routes/units, duration and exceedance interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do ATSDR minimal risk levels cover every cancer risk?
Selected-source overview · Independent review pending. Read the evidence context.
No. These levels are based on non-cancer effects and specified exposure contexts. Cancer-risk assessment is a separate question.[5]
Evidence behind this answer
- About Minimal Risk Levels
agency exposure assessment framework · 2024
Selected relevant official page passages inspected · 12 November 2024: non-cancer scope, screening purpose, routes/units, duration and exceedance interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are mg/kg/day and an airborne concentration the same exposure quantity?
Selected-source overview · Independent review pending. Read the evidence context.
No. One is a daily dose relative to body weight; the other describes air concentration. Route and units matter.[5]
Evidence behind this answer
- About Minimal Risk Levels
agency exposure assessment framework · 2024
Selected relevant official page passages inspected · 12 November 2024: non-cancer scope, screening purpose, routes/units, duration and exceedance interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is personal protective equipment the only way to reduce a hazardous workplace exposure?
Selected-source overview · Independent review pending. Read the evidence context.
No. Source controls precede personal protection.[6]
Evidence behind this answer
- Hierarchy of Controls
agency workplace prevention framework · 2024
Selected relevant official page passages inspected · 10 April 2024: five controls, source/process measures and dependence on correct use
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What a risk assessment can and cannot conclude
Exposure varies between people, and susceptibility also varies with age, health and other factors. EPA distinguishes that natural variability from uncertainty due to incomplete information. Risk characterization describes evidence together with assumptions and limitations. A number needs its exposure scenario and population; further data can refine it. Cell-culture findings, for example, require interpretation before estimating effects in an intact human body.[2]
Why uncertainty belongs in the answer
EPA requires clear communication of data limitations and assumptions. Risk estimates may change when exposure information or evidence about effects improves.[2]
Questions still to cover
Further work: substance-specific dose-response evidence and actual exposure scenarios; mixtures, developmental susceptibility and occupational exposures; validated prevention options and interpretation of commercial exposure tests.
References
- Conducting a Human Health Risk Assessment
Agency explanation
EPA · Content/publication date: not stated
Accessed: 2026-10-06 UTC · Selected page sections
Cited sections: Four assessment steps; exposure assessment - About Risk Assessment
Agency explanation
EPA · Content/publication date: not stated
Accessed: 2026-10-06 UTC · Selected page sections
Cited sections: Risk basics; data limitations and uncertainty - About the National Report on Human Exposure to Environmental Chemicals
Agency explanation
CDC · Content/publication date: 2026-08-03
Accessed: 2026-10-06 UTC · Selected page text; cited sections
Cited sections: Biomonitoring, population reference data and interpretation - Endocrine Disruptors
Agency explanation
NIEHS · Content/publication date: 2026-03-06
Accessed: 2026-10-06 UTC · Selected page text; cited sections
Cited sections: Hormonal interference, routes and evidence examples - About Minimal Risk Levels
Agency exposure assessment framework
ATSDR / CDC · Content/publication date: 2024
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: 12 November 2024: non-cancer scope, screening purpose, routes/units, duration and exceedance interpretationAssessment definitions, not a personal poisoning threshold, clinical diagnosis or cleanup standard.
- Hierarchy of Controls
Agency workplace prevention framework
CDC / NIOSH · Content/publication date: 2024
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: 10 April 2024: five controls, source/process measures and dependence on correct useWorkplace prevention framework; no individual chemical assessment or equipment selection is performed.
Scope & review
- Population
- People interpreting environmental risks
- Exposure or intervention
- Hazard and exposure assessment
- Comparison
- Exposure scenarios
- Outcomes
- Likelihood and severity of harm
- Timeframe
- Duration and frequency matter
- Jurisdiction
- US EPA framework
Selected-source educational explainer. Cited page sections or indexed abstracts were inspected as specified for each source. This is not a systematic search, a formal evidence grade, or an independent clinical expert review; topic and applicability judgments are editorial. The edition 3.8 check applies to selected additions and named reused passages; older references retain their individual access dates.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-06 UTC: Bounded foundation added with source locators, scope, and unresolved expansion areas.
- 2026-10-06 UTC: Expanded definitions, categories, evidence boundaries and locally sourced questions; selected sources checked with access limits recorded. Independent expert review remains incomplete.
- 2026-10-07 UTC: Edition 3.8: added definitions, worked distinctions and sourced questions about evidence, testing, medicines and exposure. Qualified review remains pending.
What this article still leaves open
- substance-specific dose-response evidence and actual exposure scenarios
- mixtures, developmental susceptibility and occupational exposures
- validated prevention options and interpretation of commercial exposure tests
- Substance-, route-, duration- and population-specific assessment, plus meaningful outcomes of exposure reduction.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.